A Phase 1 study of MACH-1 universal influenza vaccine
Latest Information Update: 16 Oct 2024
At a glance
- Drugs Universal influenza vaccine Orlance (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Orlance
Most Recent Events
- 10 Oct 2024 According to an Orlance Inc media release, company plans to initiate Phase 1 clinical trials in 2026.
- 01 Dec 2023 New trial record
- 28 Nov 2023 According to an Orlance Inc media release, company plans to initiate Phase 1 clinical trials for the universal influenza DNA vaccine asset in 2025.